Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsTransplantation ConditioningHodgkin DiseaseHematopoietic Stem Cell MobilizationTreatment OutcomeRecurrenceMultiple MyelomaChemotherapy, AdjuvantSurvival AnalysisRetrospective StudiesKidney TransplantationCombined Modality TherapyCyclophosphamideBlood Transfusion, AutologousAntineoplastic AgentsTransplantsCisplatinDoxorubicinGraft RejectionDisease-Free SurvivalGraft SurvivalEtoposideSurvival RateImmunosuppressive AgentsTime FactorsPrognosisNeoadjuvant TherapyBreast NeoplasmsHeart TransplantationFollow-Up StudiesNeoplasm StagingDrug Administration ScheduleTissue DonorsTransplantationMelphalanLymphoma, Non-HodgkinLung NeoplasmsMethotrexateSalvage TherapyLung TransplantationCarboplatinStem Cell TransplantationNeoplasmsCytarabineNeoplasm Recurrence, LocalCarmustineProspective StudiesIfosfamideInduction ChemotherapyPaclitaxelVinblastineAntineoplastic Agents, AlkylatingPostoperative ComplicationsCyclosporineThiotepaBleomycinGranulocyte Colony-Stimulating FactorImmunosuppressionTaxoidsPeripheral Blood Stem Cell TransplantationDrug Resistance, NeoplasmTissue and Organ ProcurementKaplan-Meier EstimateAntimetabolites, AntineoplasticNeutropeniaTacrolimusDeoxycytidineOrganoplatinum CompoundsRisk FactorsLiving DonorsAntibodies, MonoclonalNeoplasm MetastasisWhole-Body IrradiationLeukemia, Myeloid, AcuteLymphomaOvarian NeoplasmsWaiting ListsGraft vs Host DiseaseAnthracyclinesBone Marrow PurgingT-LymphocytesCarcinoma, Non-Small-Cell LungHistocompatibility TestingCytomegalovirus InfectionsChemotherapy, Cancer, Regional PerfusionTesticular NeoplasmsClinical Trials as TopicPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsMultivariate AnalysisImmunocompromised HostDose-Response Relationship, DrugFeasibility StudiesRadiotherapy, AdjuvantAdenocarcinomaNausea